{
    "paper_id": "PMC7200842",
    "metadata": {
        "title": "Computed tomography (CT) scan challenges the result of SARS-CoV-2 nucleic acid test in a suspected COVID-19 case",
        "authors": [
            {
                "first": "Kun",
                "middle": [],
                "last": "Yan",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jingfeng",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yangfan",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Shun",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Ting",
                "middle": [],
                "last": "Cai",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jianjun",
                "middle": [],
                "last": "Zheng",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "To the Editor\u2014At present, COVID-19 is a global pandemic. The reverse-transcriptase polymerase chain reaction (RT-PCR) test is the gold standard for diagnosing COVID-19. We report a case with the false-positive result of SARS-CoV-2 nucleic acid testing in which chest computed tomography (CT) findings challenged the diagnosis of COVID-19 pneumonia.1,2\n",
            "cite_spans": [
                {
                    "start": 348,
                    "end": 349,
                    "mention": "1",
                    "ref_id": null
                },
                {
                    "start": 350,
                    "end": 351,
                    "mention": "2",
                    "ref_id": null
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "On February 16, 2020, a 36-year-old man presented to a local primary healthcare clinic with a mild cough and subjective fever for 1 day. He had no history of contact with COVID-19 patients. Physical examination revealed a body temperature of 38.4\u00b0C. A routine blood panel showed normal ranges of white blood cells count (8.9\u00d7109/L), neutrophils (6.1\u00d7109/L), and lymphocytes (1.8\u00d7109/L), as well as a high level of C reactive protein (25.2 mg/L). An oropharyngeal swab tested negative for influenza A and B but positive for SAR-CoV-2 by RT-PCR on February 17. The patient\u2019s chest CT showed large, mixed, ground-glass opacity (GGO) in the lower lobe of right lung with partial consolidation, distribution along with bronchovascular bundles, and a little effusion of the right oblique fissure (Fig. 1, Panel A).",
            "cite_spans": [],
            "section": "",
            "ref_spans": [
                {
                    "start": 796,
                    "end": 797,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "\n\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "On February 18, the patient was transferred to our hospital for isolation and treatment as a \u201cconfirmed case.\u201d According to a consultation among a multidisciplinary team, the diagnosis for COVID-19 seemed to be questionable according to the CT manifestations. Therefore, some imperative measures were taken as follows: (1) the patient was isolated in a single ward; (2) the same specimen was recollected as soon as possible and testing was repeated; (3) the patient\u2019s serum was tested for the virus-specific antibody of IgM for SAR-CoV-2; (4) a blood culture for bacteria or fungi was performed; and (5) an antibacterial agent was administered (moxifloxacin hydrochloride tablets, 0. 4 g orally 4 times per day) as well as an antiviral agent (lopinavir/ritonavir tablets 400 mg/100 mg orally twice daily).",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The patient\u2019s serum tested negative for SARS-CoV-2\u2013specific IgM antibody on February 18. Consecutive samples were collected for SARS-CoV-2 testing daily from February 18 to February 20 (ie, oropharyngeal swab and sputum). All of the repeated tests of viral nucleic acid were negative. A 5-day blood culture demonstrated no growth of bacteria or fungi. The patient\u2019s symptoms gradually improved. A repeat chest CT scan on February 21 showed that the lesions in the right lower lobe had been partially absorbed (Fig. 1, panel B).",
            "cite_spans": [],
            "section": "",
            "ref_spans": [
                {
                    "start": 515,
                    "end": 516,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "On February 22, bronchoalveolar lavage fluid was collected for SARS-CoV-2 testing by RT-PCR and the result was also negative. On February 24, the patient\u2019s serum tested negative for SARS-CoV-2\u2013specific IgG antibody. All of his symptoms had disappeared by February 26. A follow-up chest CT on February 29 showed that the lesions in the right lower lobe had completely resolved (Fig. 1, panel C). After a consultation with the COVID-19 prevention and control committee in our hospital, the diagnosis was revised to community-acquired pneumonia (CAP) considering no history of contact with COVID-19 patients and the negative results of consecutive repeat RT-PCR tests and the serum antibody test. The patient was released from quarantine and was discharged on the same day.",
            "cite_spans": [],
            "section": "",
            "ref_spans": [
                {
                    "start": 382,
                    "end": 383,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Yan et al3 reported that failing to consider COVID-19 because of a positive rapid test result for dengue fever, which has serious implications not only for the patient but also for public health. Our case highlights the importance of timely recognition of a false-positive result for SARS-CoV-2 when chest CT findings do not conform to the typical changes of COVID-19 pneumonia. From the epidemic control perspective, it is imperative to isolate individuals with suspected cases of COVID-19 to protect the uninfected population. However, the suspected cases should not be housed with confirmed cases of COVID-19 to prevent the spread of this disease.",
            "cite_spans": [
                {
                    "start": 9,
                    "end": 10,
                    "mention": "3",
                    "ref_id": null
                }
            ],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig. 1.: Chest computed tomography (CT) images of a 36-year-old man with a false-positive nucleic acid test result for SARS-CoV-2. The revised diagnosis was community-acquired pneumonia. Panel A: chest CT obtained on February 16 shows large, mixed, ground-glass opacity (GGO) in the right lower lobe with partial consolidation, distribution along with bronchovascular bundles, and a little effusion of the right oblique fissure. Panel B: a CT image obtained on February 21 demonstrates that the lesions in the right lower lobe have been partially absorbed. Panel C: a CT image obtained on February 29 shows that the lesions in the lower right lobe have completely resolved.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection",
            "authors": [],
            "year": 2020,
            "venue": "Radiology",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1148/radiol.2020200463"
                ]
            }
        },
        "BIBREF1": {
            "title": "The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions",
            "authors": [],
            "year": 2020,
            "venue": "Lancet Infect Dis",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S2213-2600(20)30132-6"
                ]
            }
        },
        "BIBREF2": {
            "title": "Covert COVID-19 and false-positive dengue serology in Singapore",
            "authors": [],
            "year": 2020,
            "venue": "Lancet Infect Dis",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S1473-3099(20)30158-4"
                ]
            }
        }
    }
}